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Introduction: Post-operative pain and flare-up may occur in up to 58% of patients 
following root canal treatment. The aim was to conduct a systematic review and a 
possible meta-analysis to determine the effect of glucocorticosteroid (GCS) on pain 
following root canal treatment. Methods and Materials: Scopus, MEDLINE and 
CENTRAL databases were searched up to 30th January 2017 with broad key words. In 
addition, the reference lists in eligible papers and text books were hand-searched. 
Assessment of the eligibility of papers and data extraction were performed by two 
independent reviewers. Results: Of 9891 articles, 18 were recruited as eligible papers. 
Most of these papers showed pain reducing effect of GCS on post-endodontic pain. 
Because of wide heterogeneity among the recruited papers, it was not possible to 
perform meta-analysis. Conclusion: Based on the results of this systematic review, there 
is a vast heterogeneity amongst articles regarding the use of GCS and their effect on 
post-operative pain after endodontic treatment. Further investigations with similar 
methods and materials are needed before meta-analysis on the effect of GCS on post-
operative pain following root canal treatment can be performed 
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Introduction 
ral and dental pain is a popular complaint in the general 
population [1]. It is generally accepted that as the 
population grows older, the number of systemic diseases will 
increase and for that reason the number of patients with more 
medical complications appearing in dental clinics will increase 
[2]. One of the main reasons that prevents patients from 
attending dental offices is anxiety and fear of pain during root 
canal treatment [1, 3]. For that reason, managing pain during 
and after root canal treatment is of great importance [4-22]. 
Pain following root canal treatment (RCT) is undesirable for 
both the patient and the dental practitioner. The number of 
patients experiencing pain following RCT has been reported to 
range from 2.53% to 58% [23-26]. A meta-analysis regarding 
flare-up following RCT reported an 8.4% (SD±57) incidence of 
pain and/or swelling among 982 patients from six studies [27]. 
However, another systematic review and meta-analysis reported 
that the percentage of patients suffering pain after root canal 
treatment was dependent on the time span following the 
treatment. The authors reported 40% of the patients had post-
operative pain 24 h after root canal treatment and this decreased 
to 11% after one week [28]. 
There is consensus among investigators that the presence of 
pain following RCT is a multi-factorial phenomenon and there 
is no single reason for its occurrence [29-37]. Mechanical, 
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chemical, host and microbiological factors have been described 
as important for inducing pain following root canal treatment 
[38]. In addition, the presence of pain before treatment, 
demographic factors (such as gender and age), the pre-operative 
pulp status, the type of tooth, the type of treatment (initial or re-
treatment), and a history of allergy may all influence post-
operative pain [29, 39-42].  
Several strategies have been investigated for pain relief after 
RCT. These include pharmacological strategies -such as narcotics, 
analgesics, intra-canal and systemic glucocorticosteroid (GCS), 
non-steroidal anti-inflammatory drugs (NSAIDs), long action 
anesthetics, and antibiotics- the use of trephination, occlusal 
reduction and hypnosis [6, 11, 38, 41-43]. 
GCS are hormones that have been secreted from the adrenal 
glands and they have strong anti-inflammatory actions. Several 
reasons have been outlined for the anti-inflammatory effects of GCS 
and these include the inhibition of the formation of arachidonic 
acid from cell membrane phospholipids, the suppression of 
vasodilatation, the migration of polymorphonuclear leukocytes and 
phagocytosis [38, 44]. However, because GCS can have side effects, 
they are not routinely prescribed for systemic use for pain relief 
following RCT. 
Several investigators have used GCS for pain management 
following RCT [45-76]. However, the findings of most of these 
studies are not conclusive individually because of their 
methodological considerations and limitations.  
In the endodontics literature, despite the encouraging results 
of recent studies [69-76], no systematic review and meta-
analysis have been published to answer the debate regarding the 
benefits of using GCS for post-operative pain.  
Therefore, the aim of this study was to systematically search 
and review all available published papers regarding the use of 
CGS in endodontics to assess the effect on pain following RCT. 
Materials and Methods 
A broad search was performed to find all published papers 
reporting clinical investigations regarding the effectiveness of 
GCS on pain following RCT.  
The search strategy involved defining a clinical PICO 
question (P: problem, I: intervention, C: comparison, O: 
outcome) as follows: P, teeth with inflamed or necrotic and 
infected pulps having root canal treatment, I, GCS prescription, 
C, placebo or the name of materials were used in the control 
group(s), O, incidence of pain after root canal treatment. A wide 
range of keywords was used to search the databases (Table 1) 
and the four components of PICO were merged by “AND” in 
the final step of the search. 
In order to be included in this systematic review, articles had 
to be randomized clinical trials that were published in English 
between 1st January 1966 and 30th January 2017, and they had to 
have reported the effect of GCS on pain after RCT. The type of 
GCS, the type of control (active or non-active), the monitoring 
period, the route of intervention (intra-canal, parental or oral), 
sample size, method of pain measurement and pulp status of the 
teeth needed to be clearly explained. 
MEDLINE, CENTRAL, and Scopus databases were searched 
for the specified period. Citations and references were managed 
with EndNote version XI. The initial search revealed 9891 
citations. After reviewing their titles, abstracts and full texts step 
by step, 32 articles were selected as being potentially eligible 
papers [45-76]. The reference lists of these 32 articles, three well 
known endodontic text books [77-79] and a published study 
guide [80] were also hand-checked.  
The quality of the 32 articles [45-76] that met the inclusion 
criteria was assessed using a systematic data extraction sheet 
constructed by The Critical Appraisal Skills Programme (CASP) 
(Learning and Development, © Public Health Resource Unit, 
England 2006) [81] by two independent reviewers. Any 
disagreements between the two reviewers were checked by a 
third reviewer during a group meeting.  
Using the data extraction sheet, the first two questions of 
the questionnaire were screening questions that showed 
eligibility of the articles. The positive answer to these first two 
questions showed that the study was a randomized clinical trial 
with a clearly focused research question. Each positive answer 
to the next 8 questions had one point. Eligible papers had to 
have a minimum score of 5 out of 8. Following the use of this 
questionnaire, 24 articles passed the quality assessment but five 
of these articles were subsequently excluded [53, 59, 60, 67, 68]. 
One article [68] was excluded because it was a secondary 
analysis and had used the data of another investigation [66]; 
two articles [59, 60] were excluded because they presented their 
findings in different formats which did not allow the required 
data to be extracted for the meta-analysis; one study [67] 
evaluated the pain score following surgery; and another study 
used the criteria of a flare-up [53] which means pain and/or 
swelling following RCT that needs an emergency unscheduled 
visit. The last two studies [53, 67] were also excluded because 
of their methodological differences compared to the other 
articles. Therefore, at the end of data analysis, 18 articles were 
considered for the meta-analysis [46, 47, 50-52, 57, 58, 62, 63, 
65, 66, 69-75]. The list of articles and a summary of their 
findings are shown in Table 2. 
Results 
The minimum and maximum sample sizes of the included 
studies were 37 [52] and 475 [65], respectively. However, the 
eligible articles used quite different methodologies (Table 2), i.e., 
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the type, route of administration and doses of GCS used, the 
time intervals and the type of control groups, the method of pain 
evaluation after endodontic treatment, and the presence of pain 
before GCS administration. Hence, because of these limitations, 
the findings could not be aggregated in a meta-analysis. 
The discrepancies between the percentages and pain scores 
in the GCS group versus the control groups were considerably 
more obvious in the first 48 h after treatment.  
All investigations claimed randomly assigned individuals in 
either the GCS medication or placebo/active control groups.  
The main finding in the current study was that the route of 
GCS administration, the dose and type of medication, the type 
of placebo, the time of pain evaluation following root canal 
treatment, the method of pain evaluation, the pre-operative pulp 
status, and the presence of pain before endodontic treatment 
were quite different in the previously published papers (Table 2) 
which make it impossible to compare them with each other 
through a meta-analysis. 
Discussion 
The results of this systematic review have shown that use of GCS 
may reduce pain after RCT and the reduction in pain was much 
more prominent in the first 12-48 h after treatment. However, 
because of heterogeneity amongst the eligible papers, it was not 
possible to perform a meta-analysis on the effect of GCS on pain 
following endodontic treatment. 
Post-treatment pain after RCT is a common problem, 
particularly for the patients exhibiting pre-operative pain [38]. It 
has been reported that up to 80% of these patients may experience 
post-operative pain and the more severe the pre-operative pain 
then the more severe will be the post-operative pain. Post-
treatment pain rarely lasts longer than 72 h and usually is not so 
severe that it cannot be managed by NSAID agents [44].  
The present study was designed to search articles in which 
the effect of post-operative pain after root canal treatment was 
measured following GCS administration. It should be 
considered that measuring pain after endodontic treatment will 
not provide appropriate information regarding the effects of a 
procedural intervention or the administration of a medication. 
If there is less pain post-treatment compared to pre-treatment 
pain, then this may be a sign of appropriate intervention. 
Moreover, minor transient pain following endodontic treatment 
that can be easily managed by mild analgesics can be interpreted 
as a success in post-endodontic pain management in clinical 
applications. Although consideration of patients who report 
flare-ups and use of GCS for their pain relief may be a better 
choice for outcome of the effects of GCS prescription, it was not 
selected as the O (outcome) in the PICO question of the present 
investigation because lower flare-up prevalence following 
endodontic treatment makes it difficult to differentiate amongst 
the impacts of various interventions on post-operative pain.  
Various classes of medications have been used for pain 
management following endodontic treatment such as NSAIDs, 
opioids, acetaminophen and corticosteroids. Previous 
investigations have confirmed that patients experience their 
maximum pain during the first 24-72 h following RCT [6, 11, 22, 
28, 44]. Results of this systematic review confirm that the major 
effects of GCS on post-operative pain can be found during this 
critical early post-operative period following RCT.  
Several limitations prevented the direct combination of the 
various investigations included in this systematic review. These 
limitations were a result of differences between the studies and 
included the route of GCS administration, the type of GCS used, 
the pre-operative status of pulp and root canal system, the time 
of GCS administration, the method and time interval of pain 
evaluation, and the types of controls used. The various 
differences in methodologies among the studies did not allow 
their results to be combined and compared.  
Investigations on the effects of GCS on pain after RCT have 
used various routes of administration for the medications, either 
by injection (intra-periodontal ligament, supra-periosteal, 
intraosseous, parental) [46, 57, 58, 69, 72, 74, 75], systemic 
ingestion [50, 52, 70, 71], or as an intra-canal medicament [47, 
51, 62, 63, 65, 66, 73]. All investigations except four have used 
the medication either as a root canal dressing or as a prescribed 
medication to be taken after RCT. The three exceptions used 
GCS as a premedication prior to commencing treatment [70, 71, 
75]. Therefore, it was not possible to combine the results of these 
studies as the route of drug administration may have affected the 
final outcome. The intra-canal use of GCS may be considered to 
be safe as only a very small amount of GCS can be inserted into 
the root canal and therefore there can only be very limited, if 
any, systemic side effects [82]. In agreement with this, an animal 
study reported no significant change in corticosteroid plasma 
level following GCS intra-canal insertion [83]. In addition, 
placing the active medicament into the root canal enables it to 
work directly on the inflamed tissues around the apex of the 
tooth root by diffusing from the canal; in this situation, the root 
canal acts as a drug delivery system [82]. On the other hand, oral 
ingestion, and particularly injection, of GCS will produce higher 
doses of the drug which may provide more anti-inflammatory 
effects in the periapical tissues and therefore effectively reduce 
post-operative pain, although the systemic side effects may be 
greater. In addition, studies that employed systemic GCS [46, 50, 
52, 57, 58, 69-72, 74, 75] used known doses of the GCS [44]. 
Another limitation of performing a meta-analysis was the 
dose and the type of drug used that made it very difficult to 
compare the results of the studies. For example, some studies 
used a long-acting GCS [46, 47, 50, 57, 63, 69, 75], whilst others 
used various other compositions and forms of GCS [51, 62, 66, 
71, 73] (Table 2). Therefore, the results of these studies cannot 
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be directly compared. Meanwhile, the dose of GCS may 
influence the relief of pain following RCT. Some studies used 4 
mg of oral dexamethasone [50, 52, 70], or prednisolone [71] 
while others used parental forms of dexamethasone [57, 69, 72, 
74, 75] or a limited amount of GCS as part of an intra-canal 
medicament [47, 51, 62, 63, 65, 66, 73].  
The pre-operative status of the pulp/root canal was a further 
limitation. Some studies were performed on teeth with inflamed 
pulps [47, 52, 63, 65, 69, 70, 73-75], others were done on teeth 
with infected root canal systems and apical periodontitis [62, 
66], and some combined the results of treatment for both of 
these conditions [46, 50, 51, 57, 58, 71-73]. There is no general 
agreement among investigators that show a correlation between 
infected root canal systems with apical periodontitis and the 
presence of pain following RCT [29], although some researchers 
believe there is a higher incidence of pain following RCT for 
teeth with infected root canal systems [25, 84, 85]. 
GCS have potential side effects that should be considered 
when they are being prescribed [44]. However, two recent 
investigations reported no side effects [71, 72] associated with a 
single dose of GCS before RCT. Hence, the concerns of many 
clinicians may not be justified. 
Investigations of the effect of medicaments on pain following 
root canal treatment compared GCS to either active or placebo 
medications. Of the 19 articles reviewed in this study [46, 47, 50-
52, 57, 58, 62, 63, 65, 68, 69, 70-75], two used calcium hydroxide 
(CH) as an active control in comparison to GCS [62, 66]. 
Previous studies on the effect of CH on pain and flare-up 
following root canal treatment have reported conflicting results. 
Three studies have reported positive effects of CH in reducing 
pain after RCT [87-89], but in contrast, three other 
investigations reported that CH had no significant effect on pain 
reduction [53, 86, 90]. In accordance with these studies [53, 86, 
90] a systematic review and meta-analysis could not show 
significant impact of CH on reducing post-operative pain 
following root canal treatment [91].  
One study compared both types of active and placebo 
controls with GCS and showed that only Ketorolac had similar 
pain reduction effects [63]. Ketorolac is a NSAID which has been 
used for pain control following RCT in several investigations 
with conflicting results [92-96]. 
Apart from two studies [62, 63], the other 16 reports 
included in this systematic review [46, 47, 50-52, 57, 58, 65, 66, 
69-75] showed positive effects of GCS on pain relief after RCT 
when compared to active or passive controls. It has been 
emphasized that GCS can inhibit or suppress inflammatory 
reactions and therefore they can control inflammatory 
mediators that directly or indirectly participate in producing 
pain [44].  
The results of the present study show that GCS are much 
more effective in the immediate post-operative period of time 
(up to 48 h) following root canal treatment in comparison with 
longer time periods. This may be due to two main reasons. 
Firstly, the root canal treatment itself can reduce pain by 
eradicating the pain stimulants such as pulp tissue remnants, 
bacteria and their by-products from the root canal system [97]. 
Table 1. Selected Keywords used for the search strategy 
For propose Keyword Stage 
Vital Pulp Therapy/Vital Pulp Treatment(s)/Pulpotomy/Pulpectomy/Dental 




Root Canal Therapy/Root Canal Treatment(s)/Root Canal Obturation Root Canal/Root Canal* 




Intracanal Medication(S)/Intra-Canal Medication(S)/Intra Canal 
Medication(S)/ Root Canal Medication(S Medication/Medication* 
Corticosteroid 
Therapy 
Root Canal Dressing(S)/Intra Canal Dressing(S)/Intra-Canal Dressing(S)/Intra-
Canal Dressing(S) 
Dressing/ Dressing* 
Intra-Canal Procedure(S)/Intra-Canal Procedure(S)/Intra-Canal Procedure(S)/ 
Root Canal Procedure(S) 
Procedure/ Procedure* 
 Corticosteroid/Corticosteroid* 







Pain  Swelling/Swelling* 
Flareup(s)/Flare-up(s)/Flare up(s) Flare/Flare* 
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Secondly, half of the studies used intra-canal GCS [47, 51, 62, 63, 
65, 66, 73] and this allows direct and immediate delivery of the 
drug to the inflamed periapical tissues which results in rapid 
pain relief. This has been demonstrated by a study that used a 
corticosteroid-antibiotic paste as an intra-canal medicament 
and most of the drug diffused through the apical foramen within 
the first 3-8 h after treatment [98]. 
No studies were identified that compared different routes of 
administration or different doses of GCS and their effects on 
relief pain after RCT. Therefore, it is not possible at present to 
recommend one route or dose for GCS although intra-canal 
delivery does have some advantages as discussed above with 
respect to safety and efficacy. 
Several studies used a combination of an antibiotic and a 
corticosteroid as an intracanal medicament [62, 65, 66, 73]. It has 
been emphasized that antibiotics have no significant effect on pain 
relief after root canal treatment [38, 99] and for that reason it can 
be assumed that the pain relief following use of GCS provided the 
therapeutic effect of the medications used in these studies. 
Results of the present systematic review were based on 
published studies with reliable data bases. It is important to note 
that there may be publication bias regarding GCS effects on pain 
relief following root canal therapy. In other words, 
investigations with negative results may not have been published 
and this may have affected the results of the present meta-
analysis. Unfortunately because of the wide heterogeneity 
amongst the methodologies of these studies, the significance of 
publication bias using funnel plot and its related statistical tests 
could not be assessed. GCS have been used for controlling pain 
and swelling following oral and periodontal surgery [100, 101]. 
In endodontics, despite the positive effects of GCS that have 
been reported by several researchers [46, 47, 50-52, 57, 58, 65, 
66, 69-75], post-operative pain control strategies are mostly 
based on the use of systemic NSAID medications [38]. 
Table 2. List of articles included in the review and summaries of their results 
* Tooth characteristics - 1: Inflamed and necrotic pulps, 2: Necrotic pulps, 3: Inflamed pulps, 4: Teeth with apical periodontitis.  
** Sample size. 
† Intervention - 1: intracanal, 2: oral, 3: intra-periodontal ligament, 4: parental, 5: supraperiosteal, 6:Intraosseous 
§ Measurement Tool - 1: four categories = without pain, mild pain, moderate pain, severe pain. 2: visual analogue scale (VAS) 0-100 with 4 subcategories = mild, moderate, 
severe, very severe. 3: three categories = without or mild pain, moderate pain, and severe pain, 4: VAS 0-10 with two subcategories = without pain and painful. 5: VAS 0-100 
with three subcategories = mild, moderate, and severe pain. 6: VAS 0-9. 7: VAS 1-10., 8: VAS 0-100 with eight subcategories, 9: Heft-Parker, 10: 5 scale. 4-5: Considered as 
flare-up. 
© Prednisolone acetate 2.5% in an aqueous solution. 
® Polymixin B sulfate (10000 IU), Neomycin sulfate (5 mg), and hydrocortisone (10 mg) in an aqueous solution. 
‡ Calcium hydroxide (2.5 g), zinc oxide (0.5 g), stabilizing resin (0.05 g), polyethylene glycol 400 (1.75 mL) 
۩ Long acting methyl prednisolone 
Θ Dexamethasone tablet (4 mg) 
ʘ A cream consisting of nystatin, germacidin, and triamcinolone.  
¿R- 1: Randomized without definition, 2: Random table number, 3: Computer generated numbers, 4: Random but with evenly distributed painful teeth in different groups 
Study  TC* Int† Medication SS** Control SS Meas § Interval R¿ 
Chance et al. [51] 1 1 Meticortelone© 137 Saline 133 1 24 h 1 
Ehrmann et al. [66] 2 1 Ledermix Paste 58 







Fava [62]  2 1 Otosporin 30 
Calen Paste 
(a calcium hydroxide paste] 
30 3 48 h/1 w 1 
Glassman et al. [52] 3 2 DecadronΘ 19 Placebo 18 2 8/24/48 h 1 
Kaufman et al. [58] 1 3 Depo-Medrol ۩ 
18 Mepivacaine 3% 17 
4 24 h 1 
 None 10 
Krasner and Jackson [50] 1 2 Dexamethasone 25 Placebo 23 5 8/24 h 1 
Liesinger et al. [57] 1 4 Dexamethasone 84 Saline 22 6 4/8/24/48/72 h 1 
Rogers et al. [63] 
3 1 Dexamethasone 12 Ibuprofen 12 8 6/12/24/ 48 h 1 





   
Marshall and Walton [46] 1 4 Dexamethasone 25 Saline 25 1 4/24/ 48 h 4 
Mehrvarzfar et al. [69] 3 5 Dexamethasone 50 Placebo 50 6 6/12/24/ 48 h 1 
Moskow et al. [47] 3 1 Dexamethasone 26 Saline 24 5 24/48/ 72 h 1 
Negm [65]         3 
Post-extirpation 





1/2/4/8/12/  24 
h  Post-instrumentation 133 122 
Pochapski et al. [70] 3 2 Dexamethasone 25 Placebo 22 2 4/12/24/ 48h 1 
Jalalzadeh et al. [71] 1 2 Prednisolone 20 Placebo 20 1 6/12/24h 1 
Shaniaee et al. [72] 1 5 Dexamethasone 30 Placebo 30 2 4/8/24/48h 1 





Placebo 40 9 24h/7d 2 
Bane et al. [74] 3 6 Methylprednisolone 41 Pulpotomy 43 1 7d/6m 3 
Mehrvarzfar et al. [75] 3 3 Dexamethasone 20 Placebo 20 9 6/12/24/48h 1 
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Fewer side effects of the NSAIDs in comparison to GCS are the 
most important reasons for selecting the former medication as 
the first choice for pain relief [38]. 
Conclusion 
On the basis of this systematic review, heterogeneity in method 
and materials among the eligible studies make it impossible to 
perform a meta-analysis. More studies with similar method and 
materials and the method of evaluation are needed to perform a 
meta-analysis. 
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